相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
Yaqin Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
Marieke Sternkopf et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Hemoglobin A(1c) Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2018)
Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
Paola Simeone et al.
NUTRIENTS (2018)
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
Cristina Barale et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
Lisbeth V. Jacobsen et al.
CLINICAL PHARMACOKINETICS (2016)
Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
Alison Cameron-Vendrig et al.
DIABETES (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
Hassan Kahal et al.
BMC ENDOCRINE DISORDERS (2015)
Combination of high on-treatment platelet aggregation and low deaggregation better predicts long-term cardiovascular events in PCI patients under dual antiplatelet therapy
K. A. L. Mueller et al.
PLATELETS (2014)
Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A2 Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials
Bonnie C. Shaddinger et al.
PLOS ONE (2014)
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE-/- mouse model
Tracey Gaspari et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Effect of Exercise Training and Weight Loss on Platelet Reactivity in Overweight Patients With Coronary Artery Disease
Friederike K. Keating et al.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2013)
Effects of Omega-3 Polyunsaturated Fatty Acids on Platelet Function in Healthy Subjects and Subjects with Cardiovascular Disease
Bradley J. McEwen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
Tracey Gaspari et al.
DIABETES & VASCULAR DISEASE RESEARCH (2011)
Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry
Catherine P. M. Hayward et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Platelet abnormalities in diabetes mellitus
Jose Luis Ferreiro et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Factors Contributing to Increased Platelet Reactivity in People With Diabetes
David J. Schneider
DIABETES CARE (2009)
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease
Victor Serebruany et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Pharmacological modulation of platelet function in hypertension
AD Blann et al.
HYPERTENSION (2003)
分享论文
